Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate Cancer.
Krzyzanowska A, Barron S, Higgins DF, Loughman T, O'Neill A, Sheehan KM, Wang CA, Fender B, McGuire L, Fay J, O'Grady A, O'Leary D, Watson RW, Bjartell A, Gallagher WM. Krzyzanowska A, et al. Among authors: loughman t. Eur Urol Focus. 2023 Nov;9(6):983-991. doi: 10.1016/j.euf.2023.04.004. Epub 2023 Apr 25. Eur Urol Focus. 2023. PMID: 37105783 Free article.
Prognostic value of the 6-gene OncoMasTR test in hormone receptor-positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factors.
Lynch SM, Russell NM, Barron S, Wang CA, Loughman T, Dynoodt P, Fender B, Lopez-Ruiz C, O'Grady A, Sheehan KM, Fay J, Amberger-Murphy V, Saha A, Klinger R, Gonzalez CA, Al-Attar N, Rahman A, O'Leary D, Lanigan FT, Bracken AP, Crown J, Kelly CM, O'Connor DP, Gallagher WM. Lynch SM, et al. Among authors: loughman t. Eur J Cancer. 2021 Jul;152:78-89. doi: 10.1016/j.ejca.2021.04.016. Epub 2021 Jun 2. Eur J Cancer. 2021. PMID: 34090143 Free article.
Analytical Validation of a Novel 6-Gene Signature for Prediction of Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative, Early-Stage Breast Cancer.
Loughman T, Barron S, Wang CA, Dynoodt P, Fender B, Lopez-Ruiz C, Stapleton S, Fabre A, Quinn C, Nodin B, Jirström K, Razmara F, O'Grady A, Baird AM, Gray SG, Freixo A, Moelans CB, van Diest PJ, Duffy MJ, O'Leary D, Crown J, Bracken AP, Gallagher WM. Loughman T, et al. Clin Chem. 2022 Jun 1;68(6):837-847. doi: 10.1093/clinchem/hvac028. Clin Chem. 2022. PMID: 35312747
The OncoMasTR Test Predicts Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative Early-Stage Breast Cancer: A Validation Study in ABCSG Trial 8.
Filipits M, Rudas M, Kainz V, Singer CF, Fitzal F, Bago-Horvath Z, Greil R, Balic M, Regitnig P, Halper S, Hulla W, Egle D, Barron S, Loughman T, O'Leary D, Gallagher WM, Hlauschek D, Gnant M, Dubsky P. Filipits M, et al. Among authors: loughman t. Clin Cancer Res. 2021 Nov 1;27(21):5931-5938. doi: 10.1158/1078-0432.CCR-21-1023. Epub 2021 Aug 11. Clin Cancer Res. 2021. PMID: 34380638